# SIMIC Capital

SIMIC Capital is a Private Equity based in Shanghai, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Founded:** 2011
- **Assets under management:** Undisclosed
- **Website:** www.shcapital.com.cn

## Regulatory record

- **Reports private funds:** No

## About

SIMIC Capital is a private equity firm based in Shanghai, China. It focuses on venture capital investments.

## Sectors

- Enterprise Software
- AI/ML
- Digital Health
- FinTech
- Industrial Tech

## Questions

### What investment stages does SIMIC Capital target?

SIMIC Capital covers a broad mandate: early-stage seed and start-up rounds, expansion and growth equity, and pre-IPO or PIPE transactions. This multi-stage approach allows the firm to remain involved with portfolio companies from initial institutional capital through to public-market readiness. The blend of venture and late-stage exposure within a single platform is a distinguishing feature of its strategy.

### Which sectors does SIMIC Capital focus on?

Based on its disclosed strategy and the firm's own communications, SIMIC concentrates on enterprise software, artificial intelligence and machine learning, digital health, fintech, and industrial technology. The firm targets technology-driven companies with established business models rather than early-research-stage science projects. It draws deal flow primarily from China's Yangtze River Delta ecosystem.

### Who runs investment decisions at SIMIC Capital?

SIMIC Capital has not publicly identified its founding partners, investment committee members, or senior leadership by name. The firm's principals are understood to have backgrounds in China's technology investment sector, but specific professional histories remain unpublished. Allocators should request a management biography package directly from the firm.

### Does SIMIC participate in fund commitments or only direct deals?

SIMIC's disclosed strategy emphasizes direct investments across its stage mandate, including venture rounds, growth equity placements, and PIPE transactions. The firm has not publicly indicated whether it also makes fund-of-fund commitments to other general partners. Prospective limited partners should clarify the direct-versus-fund allocation split during diligence.

## Related profiles

- [SIMEDHealth](https://altss.com/profile/simedhealth)
- [Simile Venture Partners](https://altss.com/profile/simile-venture-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/simic-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology